Fluconazole Increases Ibuprofen Blood Levels Through CYP2C9 Enzyme Inhibition
Fluconazole inhibits the CYP2C9 enzyme in your liver, which is responsible for breaking down ibuprofen—specifically the active S-(+)-ibuprofen form—resulting in significantly higher blood concentrations of the drug. 1
The Mechanism Explained
Enzyme Inhibition
Fluconazole and voriconazole are documented inhibitors of the CYP2C9 and CYP2C19 enzymes 2. When fluconazole blocks CYP2C9, ibuprofen cannot be metabolized normally, causing it to accumulate in your bloodstream.
Magnitude of the Interaction
The clinical significance is substantial:
- S-(+)-ibuprofen blood levels increase by 82% when coadministered with fluconazole 1
- The peak concentration (Cmax) rises by 15% 1
- Research demonstrates the AUC (total drug exposure) of S-(+)-ibuprofen increases to 183% of normal levels with fluconazole 3
- The elimination half-life extends from 2.4 to 3.1 hours 3
This means you're getting nearly double the ibuprofen exposure when taking fluconazole concurrently.
Clinical Implications
Why This Matters
The S-(+)-ibuprofen isomer is the pharmacologically active form responsible for both therapeutic effects and adverse reactions. Nearly doubling its blood concentration increases the risk of:
- Gastrointestinal bleeding
- Renal toxicity
- Cardiovascular events
- Other NSAID-related adverse effects
What to Do
The FDA label explicitly recommends frequent monitoring for adverse events and toxicity related to NSAIDs when coadministered with fluconazole, and states that adjustment of NSAID dosage may be needed 1. Although not specifically studied for all NSAIDs, fluconazole has the potential to increase systemic exposure of other CYP2C9-metabolized NSAIDs including naproxen, lornoxicam, meloxicam, and diclofenac 1.
Practical Management
When fluconazole and ibuprofen must be used together:
- Consider reducing the ibuprofen dose by approximately 50%, especially when using higher initial ibuprofen doses 3
- Monitor closely for NSAID toxicity (GI symptoms, renal function changes, bleeding)
- Consider alternative analgesics that don't rely on CYP2C9 metabolism
- If using other NSAIDs metabolized by CYP2C9, apply the same precautions
Important Context
This interaction is part of a broader pattern with azole antifungals. The 2024 NCCN guidelines emphasize that azole-associated drug-drug interactions are common clinical occurrences and that the list of interactions is expansive and continues to grow 2. The guidelines specifically note that although azoles may be necessary for antifungal therapy, they should only be incorporated into treatment after consultation with an infectious disease expert 2.